<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04863755</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0086</org_study_id>
    <nct_id>NCT04863755</nct_id>
  </id_info>
  <brief_title>Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension</brief_title>
  <official_title>Change of Lifestyle in Elderly Patients With Type 2 Diabetes and Systemic Arterial Hypertension: Effects of DASH Diet and Physical Activity on Blood Pressure and Insulin Sensitivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of Health Science of Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effect of lifestyle modification through the adoption of a DASH diet, with and&#xD;
      without physical activity guidance, on blood pressure and insulin sensitivity in elderly&#xD;
      patients with type 2 diabetes and hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data regarding the effects of physical activity and DASH-type diet on blood pressure control&#xD;
      in patients with type 2 diabetes and hypertension are scarce in the literature, whether&#xD;
      evaluating these isolated interventions or together. In addition, most studies do not measure&#xD;
      BP using ABPM, which has a special importance in the assessment of pressure homeostasis in DM&#xD;
      or are short-term studies. Were only two studies have been identified in the literature that&#xD;
      evaluated the effect of the DASH diet on patients with type 2 DM; however, in both trials,&#xD;
      being elderly was not an inclusion criterion. The first was an Iranian study that&#xD;
      demonstrated in 31 non-hypertensive patients a significant reduction in BP after 8 weeks of&#xD;
      following a DASH diet. In the second ECR, we demonstrated that in 20 hypertensive type 2 DM&#xD;
      patients, all using antihypertensive drugs and with uncontrolled BP, a DASH-type diet for 4&#xD;
      weeks associated with physical activity reduced the systolic BP assessed by ABPM by 12.5&#xD;
      mmHg. However, the adopted design did not allow to separate the effect of diet from the&#xD;
      effect of physical activity. On the other hand, the effect of a single session of walking&#xD;
      followed by a 24-hour ABPM assessment showed a reduction in BP in hypertensive elderly and&#xD;
      non-hypertensive patients, also without DM. So far it is not defined in patients with type 2&#xD;
      DM and hypertension, especially the elderly, whether the DASH diet alone is as beneficial for&#xD;
      BP as its association with physical activity, particularly, considering the difficulties of&#xD;
      performing exercises in this group of patients. This is valuable information, as it would&#xD;
      reinforce the role of diet therapy intervention even if in isolation in this age group.&#xD;
      Furthermore, the role of the DASH diet with or without physical activity remains unknown on&#xD;
      insulin sensitivity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 9, 2017</start_date>
  <completion_date type="Actual">March 18, 2020</completion_date>
  <primary_completion_date type="Actual">March 18, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Blood Pressure at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>24 hours ambulatory blood pressure monitoring (ABPM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Insulin Sensitivity at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>HOMA index (using serum fasting insulin and glucose)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Glucose Profile at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Fasting glucose and A1C</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Weight at 4 months anthropometric variables</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>weight in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline BMI at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>BMI in kg/m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Skeletal muscle mass at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Skeletal muscle mass in Kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Body fat mass at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Body fat mass in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Percent body Fat at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Percent body Fat (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Total cholesterol at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Total cholesterol in mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline LDL cholesterol at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>LDL cholesterol in mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Triglycerides at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>Triglycerides in mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline HDL cholesterol at 4 months</measure>
    <time_frame>Baseline and 4 months</time_frame>
    <description>HDL cholesterol in mg/dl</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>DASH diet only</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receive a DASH diet and orientation to maintain their physical activity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DASH diet with pedometer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receive a DASH diet and orientation to increase their physical activity with a pedometer steps count</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DASH</intervention_name>
    <description>Patients receive DASH diet orientation and recommended to maintain their usual physical activity</description>
    <arm_group_label>DASH diet only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DASHPED</intervention_name>
    <description>Patients receive DASH diet orientation and recommended to increase their usual activity with the use of a pedometer</description>
    <arm_group_label>DASH diet with pedometer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 60 years or more&#xD;
&#xD;
          -  Diabetes Mellitus&#xD;
&#xD;
          -  Hypertension with poor control&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glucocorticoid use&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Acute myocardial infarction in the last 6 months&#xD;
&#xD;
          -  Heart failure classes III and IV&#xD;
&#xD;
          -  history of cirrhosis, alcoholism or use of illicit drugs&#xD;
&#xD;
          -  Dementia and malignant disease that compromises survival in 5 years&#xD;
&#xD;
          -  Serum creatinine greater than 2, 0mg / dl&#xD;
&#xD;
          -  BMI&gt; 40 kg / m²&#xD;
&#xD;
          -  Physical disability that prevents the use of a pedometer&#xD;
&#xD;
          -  Participating in another research project involving any type of intervention.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luciana Verçoza Viana</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Clínicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande Do Sul</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Elderly</keyword>
  <keyword>DASH</keyword>
  <keyword>Steps</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>after publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

